Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.546 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.486 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.546 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.486 |
CLV_PCSK_PC1ET2_1 | 30 | 32 | PF00082 | 0.546 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.470 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.567 |
DOC_CKS1_1 | 16 | 21 | PF01111 | 0.641 |
DOC_CYCLIN_RxL_1 | 46 | 56 | PF00134 | 0.515 |
DOC_MAPK_gen_1 | 30 | 38 | PF00069 | 0.530 |
DOC_MAPK_gen_1 | 39 | 47 | PF00069 | 0.446 |
DOC_WW_Pin1_4 | 15 | 20 | PF00397 | 0.588 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.521 |
LIG_14-3-3_CanoR_1 | 39 | 44 | PF00244 | 0.556 |
LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.554 |
LIG_deltaCOP1_diTrp_1 | 55 | 59 | PF00928 | 0.513 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.536 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.553 |
LIG_LIR_Apic_2 | 55 | 61 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 49 | 59 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 49 | 54 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 56 | 62 | PF02991 | 0.419 |
LIG_SH2_CRK | 10 | 14 | PF00017 | 0.631 |
LIG_SH2_STAP1 | 10 | 14 | PF00017 | 0.685 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.379 |
LIG_SUMO_SIM_par_1 | 18 | 24 | PF11976 | 0.628 |
MOD_CDK_SPK_2 | 25 | 30 | PF00069 | 0.566 |
MOD_CDK_SPxK_1 | 25 | 31 | PF00069 | 0.562 |
MOD_CDK_SPxxK_3 | 25 | 32 | PF00069 | 0.560 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.607 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.713 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.546 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.720 |
MOD_PKA_1 | 39 | 45 | PF00069 | 0.555 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.554 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.555 |
MOD_ProDKin_1 | 15 | 21 | PF00069 | 0.591 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.517 |
MOD_SUMO_for_1 | 52 | 55 | PF00179 | 0.487 |
TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.628 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.486 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.493 |
TRG_NLS_MonoCore_2 | 29 | 34 | PF00514 | 0.534 |
TRG_NLS_MonoExtC_3 | 30 | 35 | PF00514 | 0.529 |
TRG_NLS_MonoExtN_4 | 29 | 35 | PF00514 | 0.532 |
TRG_Pf-PMV_PEXEL_1 | 50 | 55 | PF00026 | 0.534 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I230 | Leptomonas seymouri | 88% | 100% |
A0A0S4JJA2 | Bodo saltans | 69% | 100% |
A0A3S7X7Y9 | Leishmania donovani | 100% | 100% |
A4HAU3 | Leishmania braziliensis | 93% | 100% |
C9ZMM4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 100% |
E9B517 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4Q2W9 | Leishmania major | 99% | 100% |